Literature DB >> 22316568

Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data.

Jonathan Rabinowitz1, Stephen Z Levine, George Garibaldi, Dragana Bugarski-Kirola, Carmen Galani Berardo, Shitij Kapur.   

Abstract

Increased attention has been given to treatment of negative symptoms and its potential impact on functional outcomes, however previous inferences have been confounded by the fact that measures of functional outcomes often use items similar to those of negative symptoms. We attempted to discern the relative effects of negative symptoms on functioning, as compared to other symptoms, using data from the National Institute of Mental Health CATIE trial of chronic schizophrenia (n=1447) by examining correlations of Positive and Negative Syndrome Scale factors, Calgary Depression Rating Scale and select items from Heinrich's and Lehman's Quality of Life Scales measuring aspects of functioning that did not overlap with negative symptoms. Baseline functioning and change in functioning were more strongly related to PANSS negative factor than any of the other symptoms - though the amount of variance explained by symptom changes in general was small. The data suggests that improvement in negative symptoms may have a distinctive and independent effect on functional outcome relative to other symptoms. This should be further tested in studies where negative symptoms improve without concomitant improvement of other symptoms.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22316568     DOI: 10.1016/j.schres.2012.01.015

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  86 in total

1.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

2.  Family burden predicts functional outcome in the early course of schizophrenia beyond psychiatric symptoms and baseline functioning.

Authors:  Nicole R DeTore; Joseph Ventura; Kenneth L Subotnik; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2018-07-07       Impact factor: 4.939

3.  Schizophrenia and autism-related disorders.

Authors:  Rebecca E Hommer; Susan E Swedo
Journal:  Schizophr Bull       Date:  2015-01-29       Impact factor: 9.306

Review 4.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

Review 5.  Vitamin supplementation in the treatment of schizophrenia.

Authors:  Hannah E Brown; Joshua L Roffman
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

6.  Individual Variation in Functional Brain Network Topography is Linked to Schizophrenia Symptomatology.

Authors:  Uzma Nawaz; Ivy Lee; Adam Beermann; Shaun Eack; Matcheri Keshavan; Roscoe Brady
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

7.  Confirmatory factor analysis of the quality of life scale and new proposed factor structure for the quality of life scale-revised.

Authors:  Kim T Mueser; Min Kim; Jean Addington; Susan R McGurk; Sarah I Pratt; Donald E Addington
Journal:  Schizophr Res       Date:  2016-10-15       Impact factor: 4.939

8.  Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.

Authors:  Tina Gupta; Henry R Cowan; Gregory P Strauss; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

9.  Self-assessment of functional ability in schizophrenia: milestone achievement and its relationship to accuracy of self-evaluation.

Authors:  Felicia Gould; Samir Sabbag; Dante Durand; Thomas L Patterson; Philip D Harvey
Journal:  Psychiatry Res       Date:  2013-03-26       Impact factor: 3.222

10.  Predictors of Placebo Response in Pharmacological Clinical Trials of Negative Symptoms in Schizophrenia: A Meta-regression Analysis.

Authors:  David Fraguas; Covadonga M Díaz-Caneja; Laura Pina-Camacho; Daniel Umbricht; Celso Arango
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.